These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7648386)

  • 21. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic response to administration of standardized dog allergen extract at differing doses.
    Lent AM; Harbeck R; Strand M; Sills M; Schmidt K; Efaw B; Lebo T; Nelson HS
    J Allergy Clin Immunol; 2006 Dec; 118(6):1249-56. PubMed ID: 17157654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin prick testing in biological standardization of allergenic products.
    Malling HJ
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):157-63. PubMed ID: 9383905
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status and regulation of allergen products in Mexico.
    Larenas Linnemann D
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():23-6. PubMed ID: 24912308
    [No Abstract]   [Full Text] [Related]  

  • 25. Current and future challenges for the allergen manufacturers.
    Jacobsen L; ;
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():31-4. PubMed ID: 24912310
    [No Abstract]   [Full Text] [Related]  

  • 26. Potency determination of allergenic extracts using mediator release of rat basophil leukemia cells.
    Hoffmann A; Vogel L; Scheurer S; Vieths S; Haustein D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):203-8. PubMed ID: 9383911
    [No Abstract]   [Full Text] [Related]  

  • 27. [MMW Drug Prize 2008 awarded. SQ allergens allow allergic patients to breathe deeply].
    Wepner U
    MMW Fortschr Med; 2008 Jun; 150(26-27):21. PubMed ID: 18681225
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory Control and Standardization of Allergenic Extracts. Proceedings of the 8th International Paul-Ehrlich-Seminar. Bethesda, Maryland, USA, March 11-13, 1996.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):1-286. PubMed ID: 9440874
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant and modified allergens: the U.S. perspective.
    Rabin RL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):191-3; discussion 193-4. PubMed ID: 17393739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen immunotherapy practice parameter update.
    Smith CS
    J Ky Med Assoc; 2004 Feb; 102(2):53-6. PubMed ID: 15004935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data.
    Letz AG; Tankersley MS; Dice JP; England RW
    J Allergy Clin Immunol; 2009 May; 123(5):1175-6. PubMed ID: 19251313
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardization of allergen extracts.
    Larsen JN; Dreborg S
    Methods Mol Med; 2008; 138():133-45. PubMed ID: 18612605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American Academy of Otolaryngic Allergy endorses the Allergen Immunotherapy Practice Parameter.
    Fass PT
    J Allergy Clin Immunol; 2008 Jan; 121(1):269-70; author reply 270. PubMed ID: 18206516
    [No Abstract]   [Full Text] [Related]  

  • 37. Usefulness of pollen chamber in the evaluation of clinical trials with allergen products.
    Krug N
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):167-70; discussion 170-1. PubMed ID: 17393736
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergenic products standardization--the role of major allergens.
    Helm RM; Burks AW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.